William Benton Jones serves as Executive at Corvus Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, William Benton Jones has executed 2 insider transactions totaling $50.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 6, 2024 involved purchasing 20,000 shares valued at $34.6K.
William Benton Jones currently holds 153,773 shares of Corvus Pharmaceuticals, Inc. (CRVS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Benton Jones has been a net buyer of CRVS stock. They have purchased $50.4K and sold $0 worth of shares.
William Benton Jones's most recent insider trade was on May 6, 2024, when they purchased 20,000 shares at $1.73 per share.
Get notified when new Form 4 filings are submitted
| $0.79 |
| Discretionary |